NCT07025629View on ClinicalTrials.gov

Dapagliflozin for Cardio-renal Protection After ICU Discharge

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

September 2, 2025

Primary Completion Date

October 15, 2028

Study Completion Date

October 15, 2028

Conditions
Heart Failure and Chronic Kidney Disease Post-ICU
Interventions
DRUG

Dapagliflozin 10 MG Oral Tablet [Farxiga]

One tablet of dapagliflozin 10 mg will be administered once daily from randomization and for 12 months period +/- 15 days..

DRUG

One tablet of placebo of dapagliflozin 10 mg

One tablet of placebo of dapagliflozin 10 mg will be administered, per os, once daily from randomization and for 12 months period ± 15 days.

Trial Locations (1)

75010

Saint Louis Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER